Patent ID: 9744134
Date: 2017-08-29
CPC Classifications: A61K

Claim:
1. An orally disintegrating tablet comprising granules A having an average particle size of 20-300 μm containing erythritol and crystalline cellulose; granules B having an average particle size of 700 μm or less containing core particles 10-500 μm in diameter, a drug, and a film-coating layer, wherein the film-coating layer covers the core particles coated with the drug; anhydrous calcium hydrogen phosphate; and crystalline cellulose, wherein the granules A are contained in an amount of 15 to 85 mass %, the granules B are contained in an amount of 3 to 70 mass %, the anhydrous calcium hydrogen phosphate is contained in an amount of 1 to 30 mass %, and the crystalline cellulose contained elsewhere besides granules A and B is contained in an amount of 1 to 20 mass % based on the weight of the tablet.